Bottom line
SHISX vs JEHSX: the short answer
SHISX (Blackrock Health Sciences Opportunities Portfolio) and JEHSX (Health Sciences Trust) are both mutual funds.
JEHSX is cheaper at 1.04% vs 1.16% — a difference of $12 a year per $10,000 invested.
Over five years, SHISX returned +5.5% a year vs +4.2% for JEHSX.
Updated Nov 19, 2026
SHISX vs JEHSX side by side
| SHISX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.16% | 1.04% |
| Annual cost per $10k | $116 | $104 |
| 10-yr cost on $10k (prospectus) | $1,409 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.05% |
| 1-yr return | +15.9% | +19.5% |
| 5-yr return (annualized) | +5.5% | +4.2% |
| 10-yr return (annualized) | +9.5% | +8.7% |
| Best quarter | +17.5% | +23.6% |
| Worst quarter | −11.5% | −16.1% |
| Net assets (fund) | $5.9B | $251.3M |
| Number of holdings | 155 | 173 |
| Portfolio turnover | 49% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHISX | JEHSX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +19.5% | −3.6% |
| 2024 | +3.8% | +1.8% | +2.0% |
| 2023 | +3.5% | +4.3% | −0.7% |
| 2022 | −6.0% | −13.1% | +7.1% |
| 2021 | +11.7% | +11.2% | +0.6% |
| 2020 | +19.4% | +27.2% | −7.7% |
| 2019 | +25.3% | +28.7% | −3.4% |
| 2018 | +8.0% | +0.7% | +7.3% |
| 2017 | +24.8% | +27.5% | −2.7% |
| 2016 | −6.1% | −10.6% | +4.5% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SHISX's top 25 holdings also appear in JEHSX's top 25.
| Holding | SHISX | JEHSX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 14.30% |
| Johnson & Johnson | 8.77% | 6.33% |
| Unitedhealth Group Inc | 6.10% | 5.95% |
| Merck & Company Inc | 4.94% | 4.21% |
| Gilead Sciences Inc | 4.19% | 2.95% |
| Abbvie Inc | 3.94% | 5.28% |
| Amgen Inc | 3.37% | 1.90% |
| Thermo Fisher Scientific Inc | 3.02% | 2.67% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.38% |
| Danaher Corp | 2.00% | 1.51% |
| Abbott Laboratories | 1.97% | 2.00% |
| Intuitive Surgical Inc | 1.95% | 1.98% |
| Elevance Health Inc | 1.56% | 1.63% |
| Stryker Corp | 1.15% | 1.87% |
Source: SEC Form N-PORT
SHISX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between SHISX and JEHSX?
Which is cheaper, SHISX or JEHSX?
Should I own both SHISX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.